BRAIN fermenter room

Bioeconomy – the biological transformation of industry

Industrial biotechnology is a driver of innovation in the transition from a petroleum-based industry to a knowledge-based bioeconomy. BRAIN has been a pacesetter and pioneer in these areas since it was founded in 1993.

Mega-trend: Bioeconomy

Challenges such as global population growth, climate change and increasing resource shortages have prompted society, policymakers and the business world to reassess the existing paradigm, and move towards a sustainable bioeconomy. The term refers to the gradual biologization of industrial processes, products and sectors – based on scientific and engineering knowledge – in order to achieve progress in environmental protection, greater product and supply security for consumers, improved raw material efficiency and the establishment of the principles of a closed-loop economy in the value chain.

External article

Altmaier launches “Industrial Bioeconomy” dialogue platform (in german)

Press release (key technologies) of the Federal Ministry of Economic Affairs and Energy

View Article

Innovation engine: Biotechnology

Industrial biotechnology is the pioneer and innovation engine for this evolutionary transformation of the economic system and of society. It offers alternatives to established, disadvantageous processes and products, and helps tackle current problems such as the proliferation of widespread diseases caused by malnutrition or elevated CO2 levels. As a technology of the future, it also enables completely new approaches and solutions that seemed unthinkable just a few years ago. It opens up previously unknown value creation paths and produces disruptive product ideas for a modern bioeconomy.

BRAIN Graphic

Investment factor: Sustainability

Global financial markets also regard the bioeconomy as a mega-trend prompting corresponding capital reallocations. Private and institutional investors have been focusing increasingly on socially responsible asset types, otherwise termed SRIs (Sustainable and Responsible Investments) or “impact investing” in reference to their intended sustainable impact. In turn, the securities of companies that fail to make corresponding efforts encounter restricted demand, or are eliminated from investment portfolios. Sustainable impact investments are registering continuous growth.

Investors

BRAIN and the bioeconomy

BRAIN AG was the first bioeconomy company to go public in Germany. The BRAIN Group's unique selling points include access to a comprehensive “Toolbox of Nature” in the form of the company's proprietary BioArchive and an extensive technology portfolio for converting natural resources into industrial applications. BRAIN actively contributes to reaching the United Nations Sustainable Development Goals.

External article

A sustainable bioeconomy for Europe: strengthening the connection between economy, society and the environment

Bioeconomy Strategy of the European Commission

View Article
External article

The Most Innovative Bioeconomy CEO 2018 is Jürgen Eck, CEO of BRAIN AG, Germany

by IL BIOECONOMISTA

View Article

Share this page